Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor

EMBO Journal

Volumn 23, Issue 1, 2004, Pages 66-76

  Rodríguez Frade, José Miguel ^a   Del Real, Gustavo ^a   Serrano, Antonio ^a   Hernanz Falcón, Patricia ^a   Soriano, Silvia F ^a   Vila Coro, Antonio J ^a   De Ana, Ana Martín ^a   Lucas, Pilar ^a   Prieto, Ignacio ^a   Martínez A, Carlos ^a   Mellado, Mario ^a,b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b CSIC   (Spain)

Author keywords

AIDS; Chemokine; Chemokine receptor; HIV 1

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CCR2 01; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEREOSPECIFICITY; TRANS ISOMER; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CALCIUM; CELL LINE; CHEMOKINE CCL2; CHEMOKINES, CC; CHEMOTAXIS; CULTURE MEDIA, SERUM-FREE; DIMERIZATION; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; GENES, REPORTER; HIV INFECTIONS; HIV-1; HUMANS; ISOLEUCINE; KINETICS; LIGANDS; MONOCYTES; PRECIPITIN TESTS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0842285404     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600020     Document Type: Article

References (50)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKRS: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958
2. 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97: 3684-3689
3. Baggiolini M, Moser B (1997) Blocking chemokine receptors. J Exp Med 186: 1189-1191
4. Bastiaens PI, Jovin TM (1996) Microspectroscopic imaging tracks the intracellular processing of a signal transduction protein: fluorescent-labeled protein kinase C beta I. Proc Natl Acad Sci USA 93: 8407-8412
5. Berger EA, Doms RA, Fenyö EM, Korber BT, Littman DR, Moore JP, Sattentau QJ, Schuitemaker H, Sodroski J, Weiss RA (1998) A new classification for HIV-1. Nature 391: 240
6. Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 co-receptors: roles in viral entry, tropism and disease. Annu Rev Immunol 17: 657-700
7. Blanpain C, Vanderwinden JM, Cihak J, Wittamer V, Le Poul E, Issafras H, Stangassinger M, Vassart G, Marullo S, Schlöndorff D, Parmentier M, Mack M (2002) Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol Cell Biol 13: 723-737
8. Chidiac P, Nouet S, Bouvier M (1996) Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor. Mol Pharmacol 50: 662-669
9. Chuntharapai A, Lee J, Burnier J, Wood WI, Hébert C, Kim KJ (1994) Neutralizing monoclonal antibodies to human IL-8 receptor A map to the NH2-terminal region of the receptor. J Immunol 152: 1783-1789
10. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666
11. Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, Broder CC (1999) A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. Virology 259: 1-6
12. Doranz BJ, Grovit-Ferbas K, Sharron MP, Mao SH, Goetz MB, Daar ES, Doms RW, O'Brien WA (1997) A small molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 186: 1395-1400
13. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85: 1149-1158
14. Frade JMR, Llorente M, Mellado M, Alcami J, Gutierrez-Ramos JC, Zaballos A, Real G, Martinez-A C (1997a) The N-terminal domain of the CCR2 chemokine receptor acts a co-receptor for HIV-1 infection. J Clin Invest 100: 497-502
15. Frade JMR, Mellado M, Lind P, Gutierrez-Ramos JC, Martínez-A C (1997b) Characterization of the CCR2 chemokine receptor; functional CCR2 receptor expression on B cells. J Immunol 159: 5576-5584
16. Fragoso R, Ren D, Zhang X, Su MW, Burakoff SJ, Jin YJ (2003) Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol 170: 913-921
17. Garzino-Demo A, DeVico AL, Conant KE, Gallo RC (2000) The role of chemokines in human immunodeficiency virus infection. Immunol Rev 177: 79-87
18. Gordon GW, Berry G, Liang XH, Levine B, Herman B (1998) Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Biophys J 74: 2702-2713
19. Issafras H, Angers S, Bulenger S, Blanpain C, Parmentier M, Labbe-Jullie C, Bouvier M, Marullo S (2002) Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 277: 34666-34673
20. Kenakin T (1997) Agonist-specific receptor conformations. Rends Pharmacol Sci 18: 416-417
21. Kenworthy AK (2001) Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods 24: 289-296
22. Littman DR (1998) Chemokine receptors: keys to AIDS pathogenesis. Cell 93: 677-680
23. Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, Wells TN, Schlondorff D, Proudfoot AE (1998) Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med 187: 1215-1224
24. Mackay CR (2001) Chemokines: immunology's high impact factor. Nat Immunol 2: 95-101
25. Mañes S, del Real G, Lacalle R, Lucas P, Gómez-Moutó n C, Sanchez-Palomino S, Delgado R, Alcamí J, Mira E, Martínez-A C (2000) Membrane raft micro-domains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 1: 190-196
26. McDermott DH, Zimmerman PA, Guignard F, Kleeberg CA, Leitman SF, Murphy PM (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Lancet 352: 866-870
27. Mellado M, Rodríguez-Frade JM, Aragay A, del Real G, Martin AM, Vila-Coro AJ, Serrano A, Mayor Jr F, Martinez-A C (1998) The chemokine monocyte chemotactic protein 1 (MCP-1) triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2b receptor. J Immunol 161: 805-813
28. Mellado M, Rodríguez-Frade JM, Kremer L, von Kobbe C, de Ana AM, Merida I, Martinez-A C (1997) Conformational changes required in the human growth hormone receptor for growth hormone signaling. J Biol Chem 272: 9189-9196
29. Mellado M, Rodríguez-Frade JM, Mañes S, Martínez-A C (2001a) Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19: 397-421
30. Mellado M, Rodríguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin de Ana A, Jones DR, Toran JL, Martinez-A C (2001b) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 20: 2497-2507
31. Mellado M, Rodríguez-Frade JM, Vila-Coro AJ, Martín de Ana A, Martínez-A C (1999) Chemokine control of HIV-1 infection. Nature 400: 723-724
32. Mengozzi M, De Filippi C, Transidico P, Biswas P, Cota M, Ghezzi S, Vicenzi E, Mantovani A, Sozzani S, Poli G (1999) Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood 93: 1851-1857
33. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2: 123-128
34. Murakami T, Nakajima T, Koyanagi Y, Tachibana K, Fujii N, Tamamura H, Yoshida N, Waki M, Matsumoto A, Yoshie O, Kishimoto T, Yamamoto N, Nagasawa T (1997) A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 186: 1389-1393
35. O'Brien SJ, Moore JP (2000) The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 17: 99-111
36. Rodríguez D, Rodríguez JR, Rodríguez JF, Trauber D, Esteban M (1989) Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc Natl Acad Sci USA 86: 1287-1291
37. Rodríguez JF, Rodríguez D, Rodríguez JR, McGowan E, Esteban M (1988) Expression of the firefly luciferase gene in a vaccinia virus: a highly sensitive gene marker to follow dissemination in tissues of infected animals. Proc Natl Acad Sci USA 85: 1667-1671
38. Rodríguez-Frade JM, Mellado M, Martínez-A C (2001) Chemokine receptor dimerization: two are better than one. Trends Immunol 22: 612-617
39. Rodríguez-Frade JM, Vila-Coro AJ, Martín de Ana A, Albar JP, Martínez-A C, Mellado M (1999) The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci USA 96: 3628-3633
40. Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242
41. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722-725
42. Schols D, Struyf S, Van Damme J, Este JA, Henson G, De Clercq E (1997) Inhibitor of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 186: 1383-1388
43. Signoret J, Pelchen-Matthews A, Mack M, Proudfoot AE, Marsh M (2000) Endocytosis and recycling of the HIV coreceptor CCR5. J Cell Biol 151: 1281-1293
44. Smith MW, Carrington M, Winkler C, Lomb D, Dean M, Huttley G, O'Brien SJ (1997a) CCR2 chemokine receptor and AIDS progression. Nat Med 3: 1052-1053
45. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ (1997b) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277: 959-965
46. Sorkin A, McClure M, Huang F, Carter R (2000) Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr Biol 10: 395-398
47. Vila-Coro AJ, Mellado M, Martin de Ana A, Lucas P, del Real G, Martinez-A C, Rodriguez-Frade JM (2000) HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc Natl Acad Sci USA 97: 3383-3393
48. Ward SG, Bacon K, Westwick J (1998) Chemokines and T lymphocytes: more than an attraction. Immunity 9: 1-11
49. Wouters FS, Bastiaens PI, Wirtz KW, Jovin TM (1998) FRET microscopy demonstrates molecular association of non-specific lipid transfer protein (nsL-TP) with fatty acid 737 oxidation enzymes in peroxisomes. EMBO J 17: 7179-7189
50. Xiao X, Wu L, Stantchev TS, Feng YR, Ugolini S, Chen H, Shen Z, Riley JL, Broder CC, Sattentau QJ, Dimitrov DS (1999) Constitutive cell surface association between CD4 and CCR5. Proc Natl Acad Sci USA 96: 7496-7501